NCT00217529: Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer |
|
|
| Completed | 1/2 | | US | pegfilgrastim, carboplatin, docetaxel, erlotinib hydrochloride | Fred Hutchinson Cancer Center | Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | 11/05 | | | |